-
1.
公开(公告)号:US20240279174A1
公开(公告)日:2024-08-22
申请号:US18626187
申请日:2024-04-03
Applicant: Duke University
Inventor: Pei Zhou , Jiyong Hong
IPC: C07D209/08 , A61K31/495 , A61K31/496 , A61K31/506 , A61K31/5377 , A61K31/551 , A61K31/706 , C07D213/72 , C07D213/89 , C07D249/04 , C07D261/18 , C07D295/26 , C07D401/12 , C07D403/12 , C07D405/12 , C07D413/12 , C07D417/12 , C07H11/04
CPC classification number: C07D209/08 , A61K31/495 , A61K31/496 , A61K31/506 , A61K31/5377 , A61K31/551 , A61K31/706 , C07D213/72 , C07D213/89 , C07D249/04 , C07D261/18 , C07D295/26 , C07D401/12 , C07D403/12 , C07D405/12 , C07D413/12 , C07D417/12 , C07H11/04
Abstract: Disclosed herein are novel antibiotic compositions and methods of making and using the same. The antibiotic compositions may comprise LPXH-targeting compounds.
-
公开(公告)号:US20240148716A1
公开(公告)日:2024-05-09
申请号:US18473202
申请日:2023-09-22
Applicant: DUKE UNIVERSITY
Inventor: Pei Zhou , Jiyong Hong
IPC: A61K31/4706 , A61K33/243
CPC classification number: A61K31/4706 , A61K33/243 , A61P35/04
Abstract: This invention relates to compounds, pharmaceutical compositions comprising them, and methods of using the compounds and compositions for treating diseases related to translesion synthesis (TLS) pathway. More particularly, this disclosure relates to small molecule inhibitors of TLS, methods of inhibiting TLS pathway with these compounds, and methods of treating diseases related to the TLS pathway.
-
公开(公告)号:US20220008408A1
公开(公告)日:2022-01-13
申请号:US17283461
申请日:2019-10-09
Applicant: DUKE UNIVERSITY
Inventor: Pei Zhou , Jiyong Hong
IPC: A61K31/4706 , A61K33/243
Abstract: This invention relates to compounds, pharmaceutical compositions comprising them, and methods of using the compounds and compositions for treating diseases related to translesion synthesis (TLS) pathway. More particularly, this disclosure relates to small molecule inhibitors of TLS, methods of inhibiting TLS pathway with these compounds, and methods of treating diseases related to the TLS pathway.
-
公开(公告)号:US20160106720A1
公开(公告)日:2016-04-21
申请号:US14886917
申请日:2015-10-19
Applicant: University of Florida Research Foundation, Inc. , Duke University , Korea Research Insitute of Chemical Technology
Inventor: Hendrik Luesch , Jiyong Hong , Seong Hwan Kim
IPC: A61K31/429 , A61K45/06
CPC classification number: A61K31/429 , A61K45/06 , C07D498/18 , A61K2300/00
Abstract: The instant invention describes macrocyclic compounds having therapeutic activity, and methods of treating disorders such as methods of modulating bone processes, and methods of treating bone-related disease, disorders, and symptoms thereof.
-
公开(公告)号:US12098117B2
公开(公告)日:2024-09-24
申请号:US17312858
申请日:2019-12-11
Applicant: DUKE UNIVERSITY
Inventor: Dennis J. Thiele , Bushu Dong , Alexander M. Jaeger , Philip F. Hughes , Timothy Haystead , Jiyong Hong
IPC: C07C275/30 , A61P35/00 , C07C211/40 , C07C255/60 , C07C275/28 , C07C275/34 , C07C275/40 , C07C275/42 , C07C279/18 , C07C279/28 , C07C281/06 , C07C311/46 , C07C317/36 , C07C317/42 , C07D213/40 , C07D213/75 , C07D223/04 , C07D229/02 , C07D231/56 , C07D233/64 , C07D241/24 , C07D249/14 , C07D271/12 , C07D285/10 , C07D317/66 , C07D333/20 , C07D333/36 , C07D333/72 , C07D405/04 , C07D405/12 , C07D417/12
CPC classification number: C07C275/30 , A61P35/00 , C07C211/40 , C07C255/60 , C07C275/28 , C07C275/34 , C07C275/40 , C07C275/42 , C07C279/18 , C07C279/28 , C07C281/06 , C07C311/46 , C07C317/36 , C07C317/42 , C07D213/40 , C07D213/75 , C07D223/04 , C07D229/02 , C07D231/56 , C07D233/64 , C07D241/24 , C07D249/14 , C07D271/12 , C07D285/10 , C07D317/66 , C07D333/20 , C07D333/36 , C07D333/72 , C07D405/04 , C07D405/12 , C07D417/12
Abstract: This disclosure relates to compounds, pharmaceutical compositions comprising them, and methods of using the compounds and compositions for treating diseases related to Heat Shock Transcription Factor 1 (HSF1) activity and/or function. More particularly, this disclosure relates to methods of inhibiting HSF1 activity with these compounds and pharmaceutical compositions thereof, and methods of treating diseases associated with HSF1 activity and/or function, such as cancer.
-
6.
公开(公告)号:US20240124400A1
公开(公告)日:2024-04-18
申请号:US17768152
申请日:2020-10-12
Applicant: DUKE UNIVERSITY
Inventor: Pei Zhou , Jiyong Hong
IPC: C07D209/30 , C07C311/20 , C07H11/04
CPC classification number: C07D209/30 , C07C311/20 , C07H11/04
Abstract: LpxH targeting compounds, compositions thereof, as well as methods for for making and using the same are disclosed herein. The LpxH target compounds typically have a structure pursuant to Formula (I) and/or a salt thereof, wherein Rb is selected from a single bond, C4 to C10 unsubstituted aryl, C4 to C10 substituted aryl, unsubstituted or substituted four to ten member heterocycle ring, C1 to C10 unsubstituted alkyl, and C1 to C10 substituted alkyl; Rc comprises hydrogen, halogen, —OH, —CO2CH3, —COOH, —CN2CF3, —CF3, —C2OH, —CONHOH, —CCOH, C4 to C10 unsubstituted aryl, C4 to C10 substituted aryl, unsubstituted or substituted four to ten member heterocycle ring, C1 to C10 unsubstituted alkyl, or C1 to C10 substituted alkyl; and Rd and Re are independently hydrogen, —OH, —COH, —COH, —COC, —COOH, Rf, or are taken together as an unsubstituted or substituted four to eight member nitrogen containing heterocycle ring.
-
公开(公告)号:US20220106265A1
公开(公告)日:2022-04-07
申请号:US17312858
申请日:2019-12-11
Applicant: DUKE UNIVERSITY
Inventor: Dennis J. Thiele , Bushu Dong , Alexander M. Jaeger , Philip F. Hughes , Timothy Haystead , Jiyong Hong
IPC: C07C275/30 , A61P35/00 , C07D271/12 , C07D233/64 , C07C275/34 , C07D285/10 , C07C311/46 , C07D231/56 , C07D317/66 , C07D333/72 , C07D229/02 , C07C225/20 , C07D213/40 , C07D213/75 , C07D333/20 , C07D417/12 , C07C279/18 , C07C281/06 , C07D241/24 , C07D405/12 , C07D249/14 , C07D333/36 , C07D405/04 , C07D223/04 , C07C317/36
Abstract: This disclosure relates to compounds, pharmaceutical compositions comprising them, and methods of using the compounds and compositions for treating diseases related to Heat Shock Transcription Factor 1 (HSF1) activity and/or function. More particularly, this disclosure relates to methods of inhibiting HSF1 activity with these compounds and pharmaceutical compositions thereof, and methods of treating diseases associated with HSF1 activity and/or function, such as cancer.
-
公开(公告)号:US20240409504A1
公开(公告)日:2024-12-12
申请号:US18812888
申请日:2024-08-22
Applicant: Duke University
Inventor: Dennis J. Thiele , Bushu Dong , Alexander M. Jaeger , Philip F. Hughes , Timothy Haystead , Jiyong Hong
IPC: C07C275/30 , A61P35/00 , C07C211/40 , C07C255/60 , C07C275/28 , C07C275/34 , C07C275/40 , C07C275/42 , C07C279/18 , C07C279/28 , C07C281/06 , C07C311/46 , C07C317/36 , C07C317/42 , C07D213/40 , C07D213/75 , C07D223/04 , C07D229/02 , C07D231/56 , C07D233/64 , C07D241/24 , C07D249/14 , C07D271/12 , C07D285/10 , C07D317/66 , C07D333/20 , C07D333/36 , C07D333/72 , C07D405/04 , C07D405/12 , C07D417/12
Abstract: This disclosure relates to compounds, pharmaceutical compositions comprising them, and methods of using the compounds and compositions for treating diseases related to Heat Shock Transcription Factor 1 (HSF1) activity and/or function. More particularly, this disclosure relates to methods of inhibiting HSF1 activity with these compounds and pharmaceutical compositions thereof, and methods of treating diseases associated with HSF1 activity and/or function, such as cancer.
-
公开(公告)号:US11801242B2
公开(公告)日:2023-10-31
申请号:US17283461
申请日:2019-10-09
Applicant: DUKE UNIVERSITY
Inventor: Pei Zhou , Jiyong Hong
IPC: A61K31/4706 , A61K33/243 , A61P35/04 , A61P35/00
CPC classification number: A61K31/4706 , A61K33/243 , A61P35/00 , A61P35/04
Abstract: This invention relates to compounds, pharmaceutical compositions comprising them, and methods of using the compounds and compositions for treating diseases related to translesion synthesis (TLS) pathway. More particularly, this disclosure relates to small molecule inhibitors of TLS, methods of inhibiting TLS pathway with these compounds, and methods of treating diseases related to the TLS pathway.
-
-
-
-
-
-
-
-